Skip to main content

Plerixafor Side Effects

Medically reviewed by Drugs.com. Last updated on Nov 11, 2023.

Applies to plerixafor: subcutaneous solution.

Serious side effects of Plerixafor

Along with its needed effects, plerixafor may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking plerixafor:

More common

Rare

Incidence not known

Other side effects of Plerixafor

Some side effects of plerixafor may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to plerixafor: subcutaneous solution.

Gastrointestinal

Very common (10% or more): Diarrhea (up to 37%), nausea (up to 34%), vomiting (up to 10%)

Common (1% to 10%): Flatulence, abdominal pain, abdominal distension, dry mouth, stomach discomfort, hypoesthesia oral, constipation, dyspepsia[Ref]

Local

Very common (10% or more): Injection site reactions (up to 34%)[Ref]

Other

Very common (10% or more): Fatigue (up to 27%)

Common (1% to 10%): Malaise[Ref]

Nervous system

Very common (10% or more): Headache (up to 22%), paresthesia (up to 20.6%), dizziness (up to 11%)

Uncommon (0.1% to 1%): Vasovagal reactions[Ref]

Musculoskeletal

Very common (10% or more): Arthralgia (up to 13%)

Common (1% to 10%): Musculoskeletal pain[Ref]

Dermatologic

Common (1% to 10%): Hyperhidrosis, erythema[Ref]

Hematologic

Common (1% to 10%): Hyperleukocytosis

Frequency not reported: Thrombocytopenia

Postmarketing reports: Splenomegaly and splenic rupture[Ref]

Psychiatric

Common (1% to 10%): Insomnia

Uncommon (0.1% to 1%): Abnormal dreams, nightmares[Ref]

Immunologic

Uncommon (0.1% to 1%): Allergic reactions

Postmarketing reports: Anaphylactic reactions including anaphylactic shock[Ref]

Cardiovascular

Rare (less than 0.1%): Myocardial infarction[Ref]

References

1. Product Information. Mozobil (plerixafor). Genzyme Corporation. 2008.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.